Xiangyu Medical Co.,Ltd (SHA:688626)
China flag China · Delayed Price · Currency is CNY
36.97
-1.07 (-2.81%)
Sep 11, 2026, 3:00 PM CST

Xiangyu Medical Co.,Ltd Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
769.18740.75733.63736.61483.87515.8
Other Revenue
12.69279.98.24.667.7
781.87767.75743.53744.81488.53523.5
Revenue Growth
2.24%3.26%-0.17%52.46%-6.68%5.65%
Cost of Revenue
268.39266.19252.61243.35170.08169.57
Gross Profit
513.48501.56490.92501.46318.44353.92
Selling, General & Admin
294.94296.28274.02210.41175.89140.42
Research & Development
169.91175.06152.02106.7592.4168.61
Other Operating Expenses
-12-8.36-7.5-9-3.60.55
Operating Expenses
454.66465.25421.73310.31264.77211.78
Operating Income
58.8236.3169.19191.1553.67142.15
Interest Expense
-1.18-5.7-3.63-2.66-0.19-
Interest & Investment Income
17.2228.9526.638.8237.5933.73
Currency Exchange Gain (Loss)
-0.28-0.190.070.020.02-0.02
Other Non Operating Income (Expenses)
0.11-2.211.042.392.612.16
EBT Excluding Unusual Items
74.757.1793.27229.7293.7178.02
Gain (Loss) on Sale of Investments
1.090.5--3.24-1.06-
Gain (Loss) on Sale of Assets
0.150.030.070.01--0.01
Asset Writedown
-4.5-0.18-0.05-0.02-0.25-
Other Unusual Items
7.2916.9213.9517.5540.644.72
Pretax Income
78.7374.43107.24244.03132.99222.72
Income Tax Expense
-3.67-1.564.3815.729.723.18
Earnings From Continuing Operations
82.475.99102.85228.31123.3199.54
Minority Interest in Earnings
0.022.170.09-1.172.172.36
Net Income
82.4278.16102.94227.14125.47201.9
Net Income to Common
82.4278.16102.94227.14125.47201.9
Net Income Growth
0.88%-24.08%-54.68%81.03%-37.85%2.87%
Shares Outstanding (Basic)
153153156158159150
Shares Outstanding (Diluted)
153153156158159150
Shares Change
-1.10%-1.75%-1.12%-0.68%6.20%24.97%
EPS (Basic)
0.540.510.661.440.791.35
EPS (Diluted)
0.540.510.661.440.791.35
EPS Growth
2.00%-22.73%-54.17%82.28%-41.48%-17.68%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-30.39-97.37-260.3-251.35-16.3731.97
Free Cash Flow Per Share
-0.20-0.64-1.67-1.59-0.100.21
Dividend Per Share
0.1800.1800.2400.5300.2400.380
Dividend Growth
-25.00%-25.00%-54.73%120.90%-36.84%2.70%
Gross Margin
65.67%65.33%66.03%67.33%65.18%67.61%
Operating Margin
7.52%4.73%9.30%25.66%10.99%27.15%
Profit Margin
10.54%10.18%13.84%30.50%25.68%38.57%
Free Cash Flow Margin
-3.89%-12.68%-35.01%-33.75%-3.35%6.11%
EBITDA
113.0286.46107.01208.5769.74153.52
EBITDA Margin
14.46%11.26%14.39%28.00%14.27%29.33%
D&A For EBITDA
54.1950.1537.8217.4116.0611.37
EBIT
58.8236.3169.19191.1553.67142.15
EBIT Margin
7.52%4.73%9.30%25.66%10.99%27.15%
Effective Tax Rate
--4.09%6.44%7.29%10.41%
Revenue as Reported
408.7767.75743.53744.81488.53523.5